232 related articles for article (PubMed ID: 38172680)
1. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
2. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.
Mizutani T; Ishizaka A; Koga M; Ikeuchi K; Saito M; Adachi E; Yamayoshi S; Iwatsuki-Horimoto K; Yasuhara A; Kiyono H; Matano T; Suzuki Y; Tsutsumi T; Kawaoka Y; Yotsuyanagi H
Microbiol Spectr; 2022 Apr; 10(2):e0168921. PubMed ID: 35254122
[TBL] [Abstract][Full Text] [Related]
3. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA.
Mazzitelli M; Trunfio M; Sasset L; Leoni D; Castelli E; Lo Menzo S; Gardin S; Putaggio C; Brundu M; Garzotto P; Cattelan AM
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336900
[TBL] [Abstract][Full Text] [Related]
8. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant.
Wang YZ; Zhou JG; Lu YM; Hu H; Xiao FF; Ge T; Wang X; Zheng L; Yu LH; Le J; Yu H; Yu GJ; Xia Q; Zhang T; Zhou WH
World J Pediatr; 2023 May; 19(5):478-488. PubMed ID: 36627507
[TBL] [Abstract][Full Text] [Related]
10. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
[TBL] [Abstract][Full Text] [Related]
11. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Outcomes and Risk Factors Among People Living with HIV.
Spinelli MA; Jones BLH; Gandhi M
Curr HIV/AIDS Rep; 2022 Oct; 19(5):425-432. PubMed ID: 35930187
[TBL] [Abstract][Full Text] [Related]
13. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
14. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
[TBL] [Abstract][Full Text] [Related]
15. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
[TBL] [Abstract][Full Text] [Related]
16. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
18. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
20. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
